The burden of subclinical atrial fibrillation didn’t predict stroke or other embolic events or the impact of direct oral anticoagulation in a NOAH-AFNET 6 substudy.
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HITPhase 2 data showed a greater than 25% absolute reduction ...
Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research ...
A new guideline for acute pulmonary embolism developed by 10 major specialty societies introduces a novel PE clinical ...
Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla., Nov. 19, ...
6.1 Optimized anticoagulant therapy should be instituted only after careful consideration of the risk and benefit for an individual patient. 6.2 The appropriateness of a treatment plan for any ...
At what platelet count can I safely initiate long-term anticoagulation with warfarin (Coumadin) in cancer patients with thrombocytopenia and persistent atrial fibrillation (AF)?—EDGAR C. SALIRE, NP-C, ...
Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents is on the rise. Anticoagulants are prescribed for many indications, including prevention ...
ORLANDO -- Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism ...
CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...
In a recent study published in JAMA Network Open, researchers compared outcomes related to three direct oral anticoagulant (DOAC) care models to prevent anticoagulation-associated adverse effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results